Genetic Signatures Limited (ASX:GSS) has postponed its Annual General Meeting from 16 November 2026 to 30 November 2026, and has withdrawn Resolution 2 relating to the re-election of Director Dr Jenny Harry, according to a Further Addendum to the Notice of Annual General Meeting filed on 12 November 2026.

Key Points

  • The AGM has been postponed from 16 November 2026 to 30 November 2026, to be held at 9:00am (Sydney time) at Gadens, Level 29, 8 Chifley Square, Sydney NSW 2000.
  • The postponement was determined to allow GSS and Microba Life Sciences Limited (ASX: MAP) additional time to negotiate and finalise the commercial terms of a Proposed Merger.
  • Resolution 2 (Re-election of Director – Dr Jenny Harry) has been withdrawn and will not be put to shareholders at the Meeting.
  • Resolutions 1, 3 and 4 remain on the agenda and will be considered at the postponed Meeting; remaining resolutions will not be renumbered.

AGM Postponement Details and Revised Timetable

The Directors determined to postpone the Meeting in accordance with clause 5.1(c) of the company's constitution. As a result of the revised date, the Entitlement Time has been updated to 7:00pm (Sydney time) on Saturday, 28 November 2026, and the Proxy Deadline is now 5:00pm (Sydney time) on Friday, 27 November 2026. Written questions to the Chair or the Auditor may be submitted by 5:00pm (Sydney time) on Monday, 23 November 2026. A new Proxy Form is not required as a result of the amendments set out in the Further Addendum.

Withdrawal of Dr Jenny Harry Re-election Resolution

Resolution 2, which concerned the re-election of Director Dr Jenny Harry, has been withdrawn and will not be put to shareholders at the Meeting. The filing states that the Board currently comprises four Directors, requiring one Director to retire by rotation under clause 6.7(b) of the constitution. Anne Lockwood will retire and, being eligible, stand for re-election at the Meeting under Resolution 3. The filing also notes that Dr Jenny Harry's appointment was recently affirmed by shareholders at the company's recent Extraordinary General Meeting, and she will continue in office as a Director.

Proxy and Voting Instructions for Remaining Resolutions

Any votes previously cast on Resolution 2, whether via the Original Proxy Form, the Replacement Proxy Form, or online, will be disregarded. Votes cast on Resolutions 1, 3 and 4 remain valid and will be counted at the postponed Meeting. Shareholders who wish to change their vote on the remaining resolutions may do so online or by contacting the company's Share Registry, provided revised voting instructions are received by the Proxy Deadline of 5:00pm (Sydney time) on Friday, 27 November 2026. The Chair of the Meeting intends to vote all available proxies in favour of each of Resolutions 1, 3 and 4.